Clinical Trials Logo

Overweight or Obesity clinical trials

View clinical trials related to Overweight or Obesity.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06445296 Recruiting - Clinical trials for Overweight or Obesity

Postprandial Effects of Animal Versus Plant-Based Protein

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

Shifting away from diets high in animal products towards more plant predominant diets is recommended by many health organizations to both reduce the negative environmental impacts of animal agriculture and to improve health outcomes. As a result, a number of plant-based meat alternatives such as Beyond Meat have been formulated to promote increased plant consumption. However, evidence is limited on the impact of newer plant-based meat alternatives on common cardiometabolic risk factors. The investigators aim to compare the acute metabolic, gastrointestinal, and inflammatory effects of a plant-based meat alternative (i.e., Beyond Meat) versus a comparable beef product within the context of high-fat, "Western-style" meal (i.e., eggs, meat, refined bread product). The investigators will also examine whether these responses differ based on whether individuals have a normal-weight or have overweight/obesity.

NCT ID: NCT06396429 Recruiting - Clinical trials for Overweight or Obesity

To Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or Obese

Start date: May 13, 2024
Phase: Phase 3
Study type: Interventional

The study aims to evaluate the efficacy and safety of HRS9531 in subjects with overweight or obese for 48 weeks.

NCT ID: NCT06372860 Recruiting - Pregnancy Clinical Trials

DPP Feasibility Study of Breastfeeding - eMOMS 2.0

Start date: April 30, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the impact of a comprehensive intervention that combines breastfeeding support with a diabetes prevention-based program (DPP) on postpartum weight retention and lactation duration among women with pre-pregnancy overweight or obesity. This intervention, named eMOMS, is delivered by a certified health coach via a mobile health (mHealth) application.

NCT ID: NCT06366399 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

The Acute T-Rex (Timing of Resistance Exercise) Study

Start date: November 15, 2023
Phase: N/A
Study type: Interventional

The primary aim of this study is to evaluate if a single bout of AM vs PM resistance exercise has different effects on insulin sensitivity and sleep. A randomized cross-over trial be used to compare resistance exercise at two different times of the day. Each condition will take place in a laboratory setting. Each condition will consist of exercise, overnight sleep, and oral glucose tolerance tests the following day. The AM exercise will occur ~1.5 hours after habitual wake, and PM exercise will occur ~11 hours after habitual wake. After a 2-6 week washout, participants will complete the other condition. The hypothesis is that PM exercise will be more beneficial than AM exercise in improving insulin sensitivity. This study could identify if there is a better time of day to perform resistance exercise to decrease risk of developing Type 2 Diabetes Mellitus.

NCT ID: NCT06305650 Recruiting - Clinical trials for Overweight or Obesity

Probiotic Influence on Obesity-Related Lipidemia

Start date: March 20, 2024
Phase: N/A
Study type: Interventional

This study aims to investigate the effects of Bifidobacterium breve BBr60 on key health indicators in overweight and obese adults. Specifically, it will assess the probiotic's impact on body composition metrics such as BMI, body fat percentage, WHR, and BMR. The inclusion criteria for participants are a BMI of ≥28 kg/m^2, targeting individuals who stand to benefit significantly from metabolic and body composition improvements.

NCT ID: NCT06128265 Recruiting - Clinical trials for Overweight or Obesity

Sleep Extension or Regularity to Reduce Diabetes Risk in African American and Black Adults

Start date: January 3, 2024
Phase: N/A
Study type: Interventional

The goal of this study is to identify an intervention that improves sleep health and consequently metabolic health by examining whether sleep extension or enforced regularity in short sleepers will have beneficial effects on diabetes and obesity risk.

NCT ID: NCT06125964 Recruiting - Cancer Clinical Trials

eMOTION Formative Study

Start date: October 6, 2023
Phase: N/A
Study type: Interventional

The eMOTION Study is a two-part ORBIT model phase 1 trial. The first part, called the Formative Study, will assess acceptability and feasibility of a novel physical activity intervention in adults at increased risk for cancer due to overweight or obesity.

NCT ID: NCT06107387 Recruiting - Clinical trials for Overweight or Obesity

Binge Eating Self-help for Teens ONLINE Pilot and Feasibility Study

BEST
Start date: February 14, 2024
Phase: N/A
Study type: Interventional

This study is a pilot clinical trial of a new guided self-help CBT for binge eating. Participants will complete an intake assessment; following determination of eligibility, participants will then complete four months of treatment (weekly guided self-help sessions). At the end of treatment, participants will complete an interview with a research clinician to assess outcomes.

NCT ID: NCT06096636 Recruiting - Clinical trials for Overweight or Obesity

National Survey of Young Adult Nutrition

NAYAN
Start date: August 29, 2023
Phase:
Study type: Observational

The purpose of this research is to better understand how people's background, habits, and other factors influence their diets and health.

NCT ID: NCT06087822 Recruiting - Clinical trials for Overweight or Obesity

Multicenter Trial Investigating Performance and Safety of the Medical Device SiPore21®

SHINE
Start date: October 5, 2023
Phase: N/A
Study type: Interventional

The present clinical investigation is a randomized, double-blinded, placebo-controlled, multicenter international trial, planned to be conducted in Poland, Romania and Slovakia. The investigation will be performed to establish clinical evidence regarding the performance and safety of the IMD and is aiming at evaluating the suitability of the IMD for the intended purpose and population.